Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders
Author:
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 10-14
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: Relationship with splanchnic vein thrombosis and arterial diseaseAmerican Journal of Hematology, 2003
- Relationships between thrombohemorrhagic complications and platelet function in patients with essential thrombocythaemiaAmerican Journal of Hematology, 2001
- Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative diseaseBritish Journal of Haematology, 2000
- Microvascular Disturbances, Thrombosis, and Bleeding in Thrombocythemia: Current Concepts and PerspectivesSeminars in Thrombosis and Hemostasis, 1997
- Relation of Platelet Abnormalities to Thrombosis and Hemorrhage in Chronic Myeloproliferative DisordersSeminars in Thrombosis and Hemostasis, 1997
- Platelet activation and thrombosis: Studies in a patient with essential thrombocythemiaAmerican Journal of Hematology, 1996
- Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatmentCritical Reviews in Oncology/Hematology, 1995
- Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor functionBritish Journal of Haematology, 1989
- Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosisBritish Journal of Haematology, 1985
- Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.Journal of Clinical Investigation, 1985